タンパク質工学の市場規模、シェア、動向、予測：製品・サービス、タンパク質タイプ、技術、エンドユーザー、地域別、2025年～2033年

タンパク質工学の世界市場規模は2024年に36億米ドルとなりました。今後、IMARC Groupは、同市場が2033年までに82億米ドルに達し、2025年から2033年にかけて9.5％のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年には40.6%という大きな市場シェアを占めています。人工知能（AI）による自動化は、タンパク質のモデリング、創薬、工業用酵素の最適化を強化し、これがタンパク質工学の市場シェアを拡大する主要因となっています。政府の資金援助が学術研究を支援し、タンパク質治療薬や合成生物学のイノベーションを加速しています。

タンパク質工学とは、望ましい結果を得るためにタンパク質配列を開発または変更するプロセスを指します。新しいタンパク質の合成や、既存の構造や配列の変更を含み、新規の機能強化のためにアミノ酸配列を変更する組換えデオキシリボ核酸（DNA）技術を用います。この技術は、工業的に使用する酵素やタンパク質の大量生産に広く利用されています。近年、研究者は医療、研究、産業、健康、バイオテクノロジーの用途に合わせた幅広いタンパク質の設計に成功しており、世界中で需要が拡大しています。

タンパク質工学の市場動向：

合成生物学への投資の高まりと、タンパク質をベースとした医薬品開発への注目の高まりが、市場開拓を促進する主な要因となっています。さらに、タンパク質医薬品の臨床結果が良好であることから、非タンパク質医薬品からタンパク質治療薬へのシフトが著しいです。これは、タンパク質欠乏性疾患の蔓延と相まって、タンパク質工学の需要を増大させています。さらに、タンパク質工学の分野における研究開発（R&D）活動への資金提供の増加など、各国政府によって実施されているいくつかの有利なイニシアチブが、市場の成長を促進しています。このほか、組み換えモノクローナル抗体（mAbs）の登場や、がんや自己免疫疾患などさまざまな疾患の治療におけるモノクローナル抗体の使用量の増加が、製品の採用率を加速させています。さらに、農薬業界では、作物の収穫量を増やしたり、バイオ燃料の生産を促進したりするために、機能を強化した酵素を生成するための応用研究が進行しており、市場成長の触媒となっています。個別化医薬品の需要の高まり、バイオシミラーや生物製剤のニーズの高まり、ヘルスケアインフラの改善、技術の進歩、製品の革新など、その他の要因も市場に明るい見通しをもたらしています。

本レポートで扱う主な質問

• タンパク質工学の市場の規模は？
• タンパク質工学の市場の将来展望は？
• タンパク質工学の市場を牽引する主要因は何か？
• タンパク質工学の市場で最大のシェアを占める地域は？
• 世界のタンパク質工学の市場における主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界のタンパク質工学市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品・サービス別

• 機器
• 試薬
• サービスとソフトウェア

第7章 市場内訳：タンパク質タイプ別

• インスリン
• モノクローナル抗体
• 凝固因子
• ワクチン
• 成長因子
• その他

第8章 市場内訳：技術別

• 非合理的タンパク質設計
• 合理的タンパク質設計

第9章 市場内訳：エンドユーザー別

• 製薬およびバイオテクノロジー企業
• 学術研究機関
• 受託研究機関

第10章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第11章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第14章 価格分析

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abzena Ltd.
  • Agilent Technologies Inc.
  • Amgen Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • Codexis Inc.
  • Danaher Corporation
  • Eli Lilly and Company
  • General Electric Company
  • Merck KGaA
  • Novo Nordisk A/S
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

List of Figures

• Figure 1: Global: Protein Engineering Market: Major Drivers and Challenges
• Figure 2: Global: Protein Engineering Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Protein Engineering Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Protein Engineering Market: Breakup by Product & Services (in %), 2024
• Figure 5: Global: Protein Engineering Market: Breakup by Protein Type (in %), 2024
• Figure 6: Global: Protein Engineering Market: Breakup by Technology (in %), 2024
• Figure 7: Global: Protein Engineering Market: Breakup by End User (in %), 2024
• Figure 8: Global: Protein Engineering Market: Breakup by Region (in %), 2024
• Figure 9: Global: Protein Engineering (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Protein Engineering (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Protein Engineering (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Protein Engineering (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Protein Engineering (Services and Software) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Protein Engineering (Services and Software) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Protein Engineering (Insulin) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Protein Engineering (Insulin) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Protein Engineering (Monoclonal Antibodies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Protein Engineering (Monoclonal Antibodies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Protein Engineering (Coagulation Factors) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Protein Engineering (Coagulation Factors) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Protein Engineering (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Protein Engineering (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Protein Engineering (Growth Factors) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Protein Engineering (Growth Factors) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Protein Engineering (Other Protein Types) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Global: Protein Engineering (Other Protein Types) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Global: Protein Engineering (Irrational Protein Design) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Global: Protein Engineering (Irrational Protein Design) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Global: Protein Engineering (Rational Protein Design) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Global: Protein Engineering (Rational Protein Design) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Global: Protein Engineering (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Global: Protein Engineering (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Global: Protein Engineering (Academic Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Global: Protein Engineering (Academic Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Global: Protein Engineering (Contract Research Organizations) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Global: Protein Engineering (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: North America: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: North America: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: United States: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: United States: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Canada: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Canada: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Asia-Pacific: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Asia-Pacific: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: China: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: China: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Japan: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Japan: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: India: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: India: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: South Korea: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: South Korea: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Australia: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Australia: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Indonesia: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Indonesia: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Others: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Others: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Europe: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Europe: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Germany: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Germany: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: France: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: France: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: United Kingdom: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: United Kingdom: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: Italy: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: Italy: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 69: Spain: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 70: Spain: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 71: Russia: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 72: Russia: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 73: Others: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 74: Others: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 75: Latin America: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 76: Latin America: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 77: Brazil: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 78: Brazil: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 79: Mexico: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 80: Mexico: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 81: Others: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 82: Others: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 83: Middle East and Africa: Protein Engineering Market: Sales Value (in Million USD), 2019 & 2024
• Figure 84: Middle East and Africa: Protein Engineering Market: Breakup by Country (in %), 2024
• Figure 85: Middle East and Africa: Protein Engineering Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 86: Global: Protein Engineering Industry: SWOT Analysis
• Figure 87: Global: Protein Engineering Industry: Value Chain Analysis
• Figure 88: Global: Protein Engineering Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Protein Engineering Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Protein Engineering Market Forecast: Breakup by Product & Services (in Million USD), 2025-2033
• Table 3: Global: Protein Engineering Market Forecast: Breakup by Protein Type (in Million USD), 2025-2033
• Table 4: Global: Protein Engineering Market Forecast: Breakup by Technology (in Million USD), 2025-2033
• Table 5: Global: Protein Engineering Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 6: Global: Protein Engineering Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 7: Global: Protein Engineering Market: Competitive Structure
• Table 8: Global: Protein Engineering Market: Key Players

The global protein engineering market size was valued at USD 3.6 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 8.2 Billion by 2033, exhibiting a CAGR of 9.5% during 2025-2033. North America currently dominates the market, holding a significant market share of 40.6% in 2024. Artificial intelligence (AI-driven) automation enhances protein modeling, drug discovery, and industrial enzyme optimization, which is a key factor expanding the protein engineering market share. Government funding supports academic research, accelerating innovations in protein therapeutics and synthetic biology.

Protein engineering refers to the process of developing or changing a protein sequence to achieve the desired result. It involves the synthesis of new proteins or amendments in the existing structure or sequence and employs recombinant deoxyribonucleic acid (DNA) technology to alter amino acid sequences for novel and enhanced functions. It is widely utilized for the production of enzymes or proteins in large quantities for use in industrial settings. In recent years, researchers have successfully engineered a wide range of proteins tailored to medicine, research, industry, health, and biotechnology applications, which is escalating their demand across the globe.

Protein Engineering Market Trends:

The rising investments in synthetic biology and the improving focus toward protein-based drug development represent the primary factors driving the market growth. Additionally, there has been a significant shift toward protein therapeutics from non-protein drugs due to their associated positive clinical outcomes. This, in confluence with the widespread prevalence of protein-deficient diseases, is increasing the demand for protein engineering. Furthermore, several favorable initiatives undertaken by the government of various countries, such as increased funding for research and development (R&D) activities in the field of protein engineering, are propelling the market growth. Besides this, the advent of recombinant monoclonal antibodies (mAbs) and the increasing usage of monoclonal antibodies to treat various diseases, such as cancer and autoimmune diseases, are accelerating product adoption rates. Moreover, the ongoing research for applications of protein engineering in the agrochemical industry to generate enzymes with enhanced function to increase the crop yield or facilitate biofuel production is catalyzing the market growth. Other factors, including the escalating demand for personalized medicines, growing need for biosimilars and biologics, improving healthcare infrastructure, technological advancements, and product innovations, are also creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Product & Services:

• Instruments
• Reagents
• Services and Software

Breakup by Protein Type:

• Insulin
• Monoclonal Antibodies
• Coagulation Factors
• Vaccines
• Growth Factors
• Others

Breakup by Technology:

• Irrational Protein Design
• Rational Protein Design

Breakup by End User:

• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abzena Ltd., Agilent Technologies Inc., Amgen Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Codexis Inc., Danaher Corporation, Eli Lilly and Company, General Electric Company, Merck KGaA, Novo Nordisk A/S, PerkinElmer Inc., Thermo Fisher Scientific Inc. and Waters Corporation.

Key Questions Answered in This Report

• 1.How big is the protein engineering market?
• 2.What is the future outlook of protein engineering market?
• 3.What are the key factors driving the protein engineering market?
• 4.Which region accounts for the largest protein engineering market share?
• 5.Which are the leading companies in the global protein engineering market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Protein Engineering Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product & Services

• 6.1 Instruments
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Reagents
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Services and Software
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Protein Type

• 7.1 Insulin
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Monoclonal Antibodies
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Coagulation Factors
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Vaccines
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Growth Factors
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by Technology

• 8.1 Irrational Protein Design
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Rational Protein Design
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by End User

• 9.1 Pharmaceutical and Biotechnology Companies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Academic Research Institutes
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Contract Research Organizations
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abzena Ltd.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Agilent Technologies Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Amgen Inc.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Bio-Rad Laboratories Inc.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Bruker Corporation
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Codexis Inc.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Danaher Corporation
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Eli Lilly and Company
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 General Electric Company
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Merck KGaA
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Novo Nordisk A/S
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis
  • 15.3.12 PerkinElmer Inc.
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis
  • 15.3.13 Thermo Fisher Scientific Inc.
    • 15.3.13.1 Company Overview
    • 15.3.13.2 Product Portfolio
    • 15.3.13.3 Financials
    • 15.3.13.4 SWOT Analysis
  • 15.3.14 Waters Corporation
    • 15.3.14.1 Company Overview
    • 15.3.14.2 Product Portfolio
    • 15.3.14.3 Financials
    • 15.3.14.4 SWOT Analysis